Abstract
We report a case of primary CNS lymphoma treated with high-dose methotrexate in the first line. After disease progression the patient received cranial radiotherapy with concomitant temozolomide, followed by rituximab plus temozolomide, with complete remission of the disease maintained for at least two years and without major toxicity.
MeSH terms
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / therapeutic use
-
Brain / diagnostic imaging
-
Central Nervous System Neoplasms / drug therapy*
-
Central Nervous System Neoplasms / radiotherapy
-
Dacarbazine / administration & dosage
-
Dacarbazine / analogs & derivatives*
-
Dacarbazine / therapeutic use
-
Female
-
Humans
-
Lymphatic Irradiation
-
Lymphoma / drug therapy*
-
Magnetic Resonance Imaging
-
Middle Aged
-
Radiography
-
Rituximab
-
Temozolomide
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Agents
-
Rituximab
-
Dacarbazine
-
Temozolomide